NPHSL proposal for HERA 2 (EU4H-2022-DGA-MS-IBA-01-02)

Grant number: 101112981

Grant search

Key facts

  • Disease

    COVID-19, Disease X
  • Start & end year

    2023
    2025
  • Known Financial Commitments (USD)

    $1,089,638.12
  • Funder

    European Commission
  • Principal Investigator

    Griškevičius Algirdas
  • Research Location

    Lithuania
  • Lead Research Institution

    NACIONALINE VISUOMENES SVEIKATOS PRIEZIUROS LABORATORIJA
  • Research Priority Alignment

    N/A
  • Research Category

    14

  • Research Subcategory

    N/A

  • Special Interest Tags

    Data Management and Data SharingInnovation

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

C/WGS project'Äôs aim is to enhance existing WGS technologies and their capacity to respond not only to new emerging SARS-Cov-2 variants, but also to other pathogens of concern in Lithuania. This project is the continuation of previous project Grant/2021/PHF/23776 and ensures the support and extension of previously implemented technologies. Significant objectives of this project would be: the use of existing technologies for implementation of new assays, improving previously implemented integration systems and initiation of new integration systems for other than SARS-CoV-2 pathogens; sustainable workflow optimization, further personnel training and increasing the visibility of the project to the public.